Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

Successful trade fair launch at the “Fokustagung Herz”

Resuscitec GmbH has introduced itself and the CARL System for the first time to a specialist audience at the 50th International Annual Meeting of the German Society for Cardiovascular Engineering (DGfK) and the 13th Joint Focus Meeting of the German Society for Thoracic, Cardiac and Vascular Surgery (DGTHG). Thus, the official sales launch was initiated. Numerous interested parties from the medical and medical technology sectors visited the company’s new trade fair booth from November 19 to 21, 2021, to learn more about the individual components of the CARL System.

CARL Sales and CARL Support answered technical and medical questions in detail and demonstrated the performance of the CARL System directly on the devices.

Many conference visitors were particularly impressed by the technical performance and the sophisticated concept of the CARL System. The three main components CARL Controller, CARL MOX and CARL Cooler were presented by the CARL Support team to the audience in a workshop on “Shifting the limits of resuscitation”. This gave the workshop participants the opportunity to test all devices in a realistic application scenario.

The next annual meeting of the DGTHG will take place from February 19-22, 2022, in Hamburg where CARL will be represented as well.

< Back